Is Obstructive Sleep Apnea a risk factor for Gestational Diabetes?

M. Cerdà Moncadas (Palma, Spain), A. Herranz Mochales (Palma, Spain), C. Ribot Quetglas (Palma, Spain), M. Barceló Nicolau (Palma, Spain), A. Álvarez Ruiz De Larriaga (Vitoria, Spain), A. Barceló Bennasar (Palma, Spain), A. Iglesias Coma (Palma, Spain), D. Morell Garcia (Palma, Spain), M. De La Peña Bravo (Palma, Spain), J. Peña Zarza (Palma, Spain), M. Bosch Artigues (Palma, Spain), M. Giménez Carrero (Palma, Spain), J. Durán Cantolla (Vitoria, Spain), J. Marín Trigo (Zaragoza, Spain), M. Codina Marcet (Palma, Spain), P. Rodríguez Rodríguez (Vitoria, Spain), C. Pía Martínez (Vitoria, Spain), M. Piñas Cebrián (Palma, Spain), A. Sánchez Barón (Zaragoza, Spain), A. Alonso Fernández (Palma, Spain), F. García Río (Madrid, Spain)

Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Cerdà Moncadas (Palma, Spain), A. Herranz Mochales (Palma, Spain), C. Ribot Quetglas (Palma, Spain), M. Barceló Nicolau (Palma, Spain), A. Álvarez Ruiz De Larriaga (Vitoria, Spain), A. Barceló Bennasar (Palma, Spain), A. Iglesias Coma (Palma, Spain), D. Morell Garcia (Palma, Spain), M. De La Peña Bravo (Palma, Spain), J. Peña Zarza (Palma, Spain), M. Bosch Artigues (Palma, Spain), M. Giménez Carrero (Palma, Spain), J. Durán Cantolla (Vitoria, Spain), J. Marín Trigo (Zaragoza, Spain), M. Codina Marcet (Palma, Spain), P. Rodríguez Rodríguez (Vitoria, Spain), C. Pía Martínez (Vitoria, Spain), M. Piñas Cebrián (Palma, Spain), A. Sánchez Barón (Zaragoza, Spain), A. Alonso Fernández (Palma, Spain), F. García Río (Madrid, Spain). Is Obstructive Sleep Apnea a risk factor for Gestational Diabetes?. 2528

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Smoking habits of patients with Obstructive Sleep Apnea Syndrome.
Source: International Congress 2019 – Challenges in tobacco control and cessation
Year: 2019

Smoking in Obstructive Sleep Apnea Syndrome: gender differences
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020


Obstructive Sleep Apnoea is a Pulmonary Embolism severity risk factor.
Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Year: 2017

Obstructive Sleep Apnea in patients with Primary-Open Angle Glaucoma: prevalence and associations.
Source: International Congress 2018 – Obesity: comorbidities
Year: 2018

Asthma  and  Obstructive Sleep Apnea Syndrome (OSAS)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Thyroid Functions in Obstructive Sleep Apnea Patients
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021


Can the Sleep Clinical Record diagnose moderate-to-severe Obstructive Sleep Apnea Syndrome in children?
Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness
Year: 2021


Predictive factors of residual events after weight loss in Obstructive Sleep Apnea Syndrome.
Source: International Congress 2018 – Obesity: comorbidities
Year: 2018

Diagnosis of Moderate-to-severe Obstructive Sleep Apnea Syndrome based on the Sleep clinical record.
Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children
Year: 2019


Obstructive Sleep Apnea Syndrome clinical presentation  in elderly patients
Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea
Year: 2020


Influence of Obstructive Sleep Apnea on systemic inflammation in pregnancy
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020


Evidence of Obstructive Sleep Apnea among First Nations People
Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea
Year: 2020


Ischemia modified albumin in Patients with Obstructive Sleep Apnea Syndrome
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018

Investigation of Obstructive Sleep Apnea in Adult Non-Cystic Fibrosis Bronchiectasis Patients
Source: International Congress 2019 – Clinical problems
Year: 2019


Periodic Leg Movements are Associated With Cardiovascular Disease and Severity of Obstructive Sleep Apnea Syndome
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018


In search of precision for diagnosis of Obstructive Sleep Apnea
Source: Sleep and Breathing Conference 2021
Year: 2021




Obstructive sleep apnoea syndrome and a calculation of cardiovascular risk
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014


Obstructive Sleep Apnea syndrome (OSAS): A threatening ghost for ß Thalassemia Major Children
Source: International Congress 2018 – Improvements in the assessment of paediatric physiology
Year: 2018

The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
Source: Sleep and Breathing Conference 2021
Year: 2021




Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA)
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017